Bookbuilding IPO | ₹48 Cr | Listed at NSE SME | Wed, May 17, 2023 - Fri, May 19, 2023
| Category | QIB | NII | Retail | Total | ||
|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | ||||
| Allocation (No. of shares) | 73,700 | 1,10,500 | 1,84,200 | 55,300 | 1,29,000 | 3,68,500 |
| Allotment price (Rs.) | 1,229 | 1,229 | 1,229 | 1,229 | 1,229 | 1,229 |
| No.of applications | 19 | 2 | 21 | 2,454 | 47,647 | 50,122 |
| No.of shares applied | 14,10,000 | 1,18,000 | 15,28,000 | 93,85,100 | 47,64,700 | 1,56,77,800 |
| Amount collected (Rs.cr.) | 173.29 | 14.50 | 187.79 | 1,153.43 | 585.58 | 1,926.80 |
| No.of times subscribed | 19.13 | 1.07 | 8.30 | 169.71 | 36.94 | 42.54 |
| No.of shares allotted | 73,700 | 1,10,500 | 1,84,200 | 55,300 | 1,29,000 | 3,68,500 |
| Amount (Rs.cr.) | 9.06 | 13.58 | 22.64 | 6.80 | 15.85 | 45.29 |
| No.of allottees | 19 | 2 | 21 | 403 | 1,290 | 1,714 |
Remus Pharmaceuticals IPO is a public issue of 0.04 Cr equity shares. The issue offers 0.01 Cr shares to retail investors, 0.02 Cr shares to qualified institutional buyers, and 0.01 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 19,500 | 2.40 | 5.03% |
| QIB | 1,84,200 | 22.64 | 47.47% |
| Anchor | 1,10,500 | 13.58 | 28.48% |
| QIB (Ex Anchor) | 73,700 | 9.06 | 18.99% |
| NII | 55,300 | 6.80 | 14.25% |
| Retail | 1,29,000 | 15.85 | 33.25% |
| Total | 3,88,000 | 47.69 | 100% |
A total of 1,10,500 shares at a price of Rs 1,229 per share will be allotted to the anchor investors.
| Anchor investors bid opening date | May 16, 2023 |
| Anchor investor price | ₹1,229.00 |
| Anchor investors as % of QIBs | 59.99% |
| No. of shares locked-in for 30 days | 55,250 |
| No. of shares locked-in for 90 days | 55,250 |
📑 Anchor Investor Allotment Letter
📊 Historic report - IPOs Anchor Investors Investment & Performance
| S.No. | Anchor Investor | Group Entity | No. of Shares Allotted | Amount (Rs.cr.) | % Allotment within Anchor Investor Portion | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | CHHATTISGARH INVESTMENTS LTD. | CHHATTISGARH INVESTMENTS | 1,01,700 | 12.50 | 92.04 | 26.21 |
| 2 | NAV CAPITAL VCC | NAV CAPITAL | 8,800 | 1.08 | 7.96 | 2.27 |
| 1,10,500 | 13.58 | 100 | 28.48 |
The Remus Pharmaceuticals IPO is subscribed 57.21 times by May 19, 2023 19:29.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 10.75 |
| Non Institutional | 229.31 |
| Retail Individual | 49.81 |
| Total Subscription | 57.21 |
An investor can apply in Remus Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Remus Pharmaceuticals IPO shares are offered online only.
The Remus Pharmaceuticals IPO is subscribed 57.21 times by May 19, 2023 19:29.
The Remus Pharmaceuticals IPO allotment status is expected on or around Wednesday, May 24, 2023. Visit Remus Pharmaceuticals IPO allotment status to check.
The Remus Pharmaceuticals IPO listing date is May 29, 2023. The equity share of Remus Pharmaceuticals IPO will list on NSE SME.
Visit Remus Pharmaceuticals IPO subscription status page for real-time bidding information about Remus Pharmaceuticals IPO.
| IPO opens On | Wednesday, May 17, 2023 |
| IPO Closes On | Friday, May 19, 2023 |
| Finalisation of Basis of Allotment | Wednesday, May 24, 2023 |
| Initiation of Refunds | Thursday, May 25, 2023 |
| Credit of Shares to Demat Account | Friday, May 26, 2023 |
| IPO Listing Date | Monday, May 29, 2023 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
